[EN] KINASE INHIBITORS CAPABLE OF INCREASING THE SENSITIVITY OF BACTERIAL PATHOGENS TO B-LACTAM ANTIBIOTICS<br/>[FR] INHIBITEURS DE KINASES CAPABLES DE RENFORCER LA SENSIBILITÉ D'AGENTS PATHOGÈNES BACTÉRIENS AUX ANTIBIOTIQUES DE LA FAMILLE DES B-LACTAMINES
申请人:SEATTLE CHILDREN S RES INST
公开号:WO2013066469A2
公开(公告)日:2013-05-10
Staphylococcus aureus are gram-positive bacteria that are currently the leading cause of invasive infections in humans. While antibiotic therapy is currently used to treat S. aureus infections, the emergence of antibiotic resistant strains such as those resistant to methicillan are rapidly exhausting treatment options. Disclosed herein are methods and compositions for increasing the sensitivity of bacterial pathogens to β-lactam antibiotics. Also disclosed herein are genes involved in modulating antibiotic resistance which serve as novel targets for treatments aimed at inhibiting antibiotic resistant bacterial pathogens. Also disclosed herein are kinase inhibitors which demonstrate superior activity in sensitizing bacterial pathogens to β-lactam antibiotics.